Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Operating Expenses (2010 - 2026)

Updated

Elite Pharmaceuticals (ELTP) recorded Operating Expenses of $5.98 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 8.2% from $5.53 million a year earlier but down 43.5% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Operating Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, Elite Pharmaceuticals' Operating Expenses came in at $26.36 million as of Jun 30, 2026, up 23.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $25.91 million, up 26.5% from FY2025.

  • Annual Operating Expenses has increased for four straight fiscal years, with a five-year compound annual growth rate of 21.6% (FY2021 to FY2026).
  • Across earlier fiscal years, Operating Expenses came in at $20.49 million in FY2025 (+31.6%), $15.57 million in FY2024 (+20.5%), $12.92 million in FY2023 (+32.8%) and $9.72 million in FY2022 (-0.4%).
  • Quarterly Operating Expenses has ranged from $2.19 million in fiscal Q3 2022 to $10.59 million in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in seven of the last eight quarters, with growth averaging 23.8%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 72.4% in fiscal Q4 2026, against a decline of 21.5% in fiscal Q3 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $10.59 million (Q4 2026), $3.94 million (Q3 2026) and $5.86 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 Elite Pharmaceuticals 268.12 Mn 149.80 Mn 13.51 Mn 5.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.98 Mn
Mar 31, 2026 10.59 Mn
Dec 31, 2025 3.94 Mn
Sep 30, 2025 5.86 Mn
Jun 30, 2025 5.53 Mn
Mar 31, 2025 6.14 Mn
Dec 31, 2024 5.02 Mn
Sep 30, 2024 4.71 Mn
Jun 30, 2024 4.61 Mn
Mar 31, 2024 4.39 Mn
Dec 31, 2023 3.51 Mn
Sep 30, 2023 4.52 Mn
Jun 30, 2023 3.15 Mn
Mar 31, 2023 3.83 Mn
Dec 31, 2022 2.96 Mn
Sep 30, 2022 2.74 Mn
Jun 30, 2022 2.98 Mn
Mar 31, 2022 2.56 Mn
Dec 31, 2021 2.19 Mn
Sep 30, 2021 2.35 Mn
API Access

Elite Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY